A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
Status:
Not yet recruiting
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of various doses of AND017
after 6 weeks of treatment in subjects with anemia of cancer who are not receiving
chemotherapy.